CV Sciences, Inc. Introduces New THC Offering
+PlusCBD™ Reserve Collection Extra Gummies provide easy-to-dose 5mg THC option
SAN DIEGO, April 3, 2023 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced the launch of +PlusCBD™Reserve Collection Extra Gummies, the latest addition to the Company’s popular +PlusCBD product line.
Related news for (CVSI)
- CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs
- CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024
- CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER
- CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
- CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews